机构:[1]Department of Molecular and Cellular Biology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Miyagi, Japan[2]Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan[3]State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases &, Department of General and Emergency Dentistry, West China Hospital of Stomatology, Sichuan University, Chengdu, China
The small GTPases RalA and RalB are members of the Ras family, and activated downstream of Ras. Ral proteins are found in GTP-bound active and GDP-bound inactive forms. The activation process is executed by guanine nucleotide exchange factors while inactivation is mediated by GTPase-activating proteins (GAPs). RalGAPs are complexes that consist of a catalytic α1 or α2 subunit together with a common β subunit. Several reports implicate the importance of Ral in pancreatic ductal adenocarcinoma (PDAC). However, there are few reports on the relationship between levels of RalGAP expression and malignancy in PDAC. We generated RalGAPβ-deficient PDAC cells by CRISPR-Cas9 genome editing to investigate how increased Ral activity affects malignant phenotypes of PDAC cells. RalGAPβ-deficient PDAC cells exhibited several-fold higher Ral activity relative to control cells. They had a high migratory and invasive capacity. The RalGAPβ-deficient cells grew more rapidly than control cells when injected subcutaneously into nude mice. When injected into the spleen, the RalGAPβ-deficient cells formed larger splenic tumors with more liver metastases, and unlike controls, they disseminated into the abdominal cavity. These results indicate that RalGAPβ deficiency in PDAC cells contributes to high activities of RalA and RalB, leading to enhanced cell migration and invasion in vitro, and tumor growth and metastasis in vivo.
This article is protected by copyright. All rights reserved.
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类|2 区医学
小类|2 区肿瘤学
最新[2023]版:
大类|2 区医学
小类|2 区肿瘤学
第一作者:
第一作者机构:[1]Department of Molecular and Cellular Biology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Miyagi, Japan[2]Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan
通讯作者:
通讯机构:[1]Department of Molecular and Cellular Biology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Miyagi, Japan[*1]Department of Molecular and Cellular Biology, Institute of Development, Aging and Cancer, Tohoku University, Seiryo-machi 4-1, Aoba-ku, Sendai, Miyagi 980-8575, Japan.
推荐引用方式(GB/T 7714):
Yoshimachi Shingo,Shirakawa Ryutaro,Cao Mingxin,et al.The Ral GTPase-activating protein regulates the malignancy of pancreatic ductal adenocarcinoma.[J].Cancer science.2021,112(8):3064-3073.doi:10.1111/cas.14970.
APA:
Yoshimachi Shingo,Shirakawa Ryutaro,Cao Mingxin,Trinh Duc Anh,Gao Pan...&Horiuchi Hisanori.(2021).The Ral GTPase-activating protein regulates the malignancy of pancreatic ductal adenocarcinoma..Cancer science,112,(8)
MLA:
Yoshimachi Shingo,et al."The Ral GTPase-activating protein regulates the malignancy of pancreatic ductal adenocarcinoma.".Cancer science 112..8(2021):3064-3073